Category archive

Public Health

Public Health

Cholera Case in Syrian Refugee Camp: Ominous Signals

According to a report disseminated by the ProMED mail service, a case of cholera has been detected in a refugee camp housing displaced people from Homs. The translated report reads as below: The 1st case of cholera has been recorded in Zogra camp near Jarabulus city (125 km or 78 mi north of Aleppo) at… Keep Reading

Clinical Research in Times of Ebola… and other Epidemics

As the news trickles in about the raging cholera outbreak in Yemen, and an emerging outbreak is being dealt with urgently in North-Eastern Nigeria, we are more frequently being confronted with the uncomfortable question of leveraging these situations to conduct clinical research activities. The National Academies of Science, Engineering and Medicine (NASEM) have come out… Keep Reading

The Manhattan Principles

From the CDC Webpage on the twelve Manhattan Principles: These “Manhattan Principles” urge world leaders, civil society, the global health community, and institutions of science to holistically approach the prevention of epidemic/epizootic disease and the maintenance of ecosystem integrity by: Recognizing the link between human, domestic animal, and wildlife health, and the threat disease poses… Keep Reading

Comparing the Rotavirus Vaccines in India

Comparisons of different rotavirus vaccines are difficult to make with a lot of precision because of the differing populations, protocols, attack rates, and study procedures which have been employed to assess the efficacy of the vaccines. Given the rather recent deployment of the vaccines, there are very limited evidence on their effectiveness in the population/community-setting.… Keep Reading

Placeholder

BGR-34 for Diabetes: Where is the evidence?

An herbal drug, developed jointly by the National Botanical Research Institute (NBRI) and the Central Institute of Medicinal and Aromatic Plants (CIMAP), branded as BGR-34, has been commercialized by Delhi-based Aimil Pharmaceuticals and marketed as a potentially side-effect free treatment for diabetes. However, a search for publications outlining trials conducted to support the claimed “67%… Keep Reading

Placeholder

Turning to the "Infected Jelly" to Treat Ebola

The NEJM has come out with a very interesting paper: Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. The explosive outbreak of Ebola Virus Disease in West Africa last year had hijacked the headlines and media space in a big way. Multiple solutions were touted, including the vaccine trial STRIVE. Few articles, however, looked… Keep Reading

Placeholder

If Carbapenems Go, Can Colistin be Far Behind?

I wrote about the disaster-in-the-making discovery of transmissible resistance to colistin, a last resort antibiotic, when the Lancet Infectious Diseases published a paper based on data coming out from surveillance in China. At that point of time, the isolation of the transmissible gene providing resistance (mcr1 gene) gained a lot of attention. Maryn McKenna’s blog post went… Keep Reading

1 2 3 7
Go to Top